Xianying Xing Selected Research

Xianying Xing Research Topics

Disease

26	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2023 - 02/2011
12	Inflammation (Inflammations) 03/2024 - 06/2016
3	Atopic Dermatitis (Atopic Eczema) 07/2023 - 01/2020
3	Wounds and Injuries (Trauma) 11/2022 - 01/2019
2	Prurigo 07/2023 - 01/2022
2	Bites and Stings (Sting) 01/2023 - 11/2022
2	Skin Diseases (Skin Disease) 01/2023 - 02/2011
2	Atherosclerosis 01/2022 - 10/2017
2	Leukemia 01/2022 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2017
1	Dermatitis 03/2024
1	Necrobiosis Lipoidica 02/2024
1	Lichen Planus (Lichen Ruber Planus) 01/2024
1	Necrosis 12/2023
1	Pathologic Processes 07/2023
1	Acne Vulgaris 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Pemphigus (Pemphigus Vulgaris) 01/2022
1	Pruritus (Itching) 01/2022
1	Pityriasis Rubra Pilaris 10/2021
1	Abdominal Aortic Aneurysm 01/2021
1	Aortic Rupture 01/2021
1	Psoriatic Arthritis 01/2020
1	Hidradenitis Suppurativa 01/2019
1	Exanthema (Rash) 01/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Cutaneous Lupus Erythematosus 01/2017
1	Thrombosis (Thrombus) 12/2016
1	Atherosclerotic Plaque (Atheroma) 12/2016
1	Atrophy 01/2016
1	Fibrosis (Cirrhosis) 04/2008
1	Colonic Neoplasms (Colon Cancer) 03/2008
1	Neoplasm Metastasis (Metastasis) 03/2008
1	Neoplasms (Cancer) 03/2008

Drug/Important Bio-Agent (IBA)

16	CytokinesIBA 11/2022 - 02/2011
10	RNA (Ribonucleic Acid)IBA 07/2023 - 07/2014
6	Interleukin-17 (Interleukin 17)IBA 03/2024 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2008
4	Imiquimod (Aldara)FDA LinkGeneric 01/2022 - 04/2011
3	Messenger RNA (mRNA)IBA 09/2023 - 01/2015
3	Interleukin-6 (Interleukin 6)IBA 11/2022 - 12/2016
3	Interleukin-1 (Interleukin 1)IBA 10/2021 - 02/2011
2	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2019
2	nemolizumabIBA 07/2023 - 01/2022
2	InterferonsIBA 01/2023 - 01/2019
2	Histone DemethylasesIBA 11/2022 - 01/2021
2	Histone MethyltransferasesIBA 01/2022 - 01/2019
2	AntibodiesIBA 01/2022 - 12/2016
2	Interleukin-12 (IL 12)IBA 01/2022 - 05/2013
2	EnzymesIBA 01/2022 - 10/2021
2	Etanercept (Enbrel)FDA Link 01/2022 - 02/2011
2	Interleukin-23 (Interleukin 23)IBA 12/2016 - 05/2013
1	ruxolitinibIBA 02/2024
1	baricitinibIBA 01/2024
1	Methotrexate (Mexate)FDA LinkGeneric 09/2023
1	P-2 (P 2)IBA 09/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Cytidine DeaminaseIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Cadherins (E-Cadherin)IBA 01/2022
1	Proprotein Convertase 9IBA 01/2022
1	Benzoyl Peroxide FDA LinkGeneric 01/2022
1	CollagenIBA 01/2022
1	Free RadicalsIBA 01/2022
1	LipidsIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	SqualeneIBA 01/2022
1	Squalene Monooxygenase (Squalene Epoxidase)IBA 01/2022
1	Phospholipases A2 (Phospholipase A2)IBA 10/2021
1	Phospholipases (Phospholipase)IBA 10/2021
1	Pancreatic Elastase (Elastase)IBA 01/2021
1	Angiotensin IIIBA 01/2021
1	Histones (Histone)IBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	vorapaxarIBA 01/2020
1	Kallikreins (Kallikrein)IBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Serine Proteases (Serine Protease)IBA 01/2020
1	PAR-1 ReceptorIBA 01/2020
1	Uric Acid (Urate)IBA 01/2019
1	MethyltransferasesIBA 01/2019
1	B-Cell Activating FactorIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2019
1	ChemokinesIBA 01/2019
1	Inflammation MediatorsIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2016
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 06/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Complementary DNA (cDNA)IBA 07/2014
1	Chemokine CXCL10IBA 05/2013
1	Peptides (Polypeptides)IBA 02/2011
1	Antimicrobial PeptidesIBA 02/2011
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2008
1	Antisense OligonucleotidesIBA 03/2008
1	Type I Tumor Necrosis Factor ReceptorsIBA 03/2008

Therapy/Procedure

4	Therapeutics 01/2023 - 02/2011